BioCrude Technologies USA, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BioCrude Technologies USA, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • BioCrude Technologies USA, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $418K, a 13.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $418K +$51.2K +13.9% Dec 31, 2023 10-K 2024-03-27
Q4 2022 $367K -$325K -47% Dec 31, 2022 10-K 2024-03-27
Q4 2021 $692K +$90K +15% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $602K +$59K +10.9% Dec 31, 2020 10-K 2022-03-23
Q4 2019 $543K +$58K +12% Dec 31, 2019 10-K 2021-02-12
Q4 2018 $485K +$245K +102% Dec 31, 2018 10-K 2020-03-20
Q4 2017 $240K -$47K -16.4% Dec 31, 2017 10-K 2019-04-17
Q4 2016 $287K Dec 31, 2016 10-K/A 2018-11-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.